DAFTAR PUSTAKA 9A
2
DAFTAR PUSTAKA Zand, Negin, dkk. 2005. Allele Frequency of CYP2C19 Gene Polymorphisms in a Healthy Iranian Population. Iran : Iran University of Medical Sciences. Chaudhry, A.S, dkk. 2008. Genetic polymorphism of CYP2C19 & therapeutic response to proton pump inhibitors. India : Departments of Biochemistry & *Gastroenterology, Postgraduate Institute of Medical Education & Research, Chandigarh. Dogné, Jean-Michel, dkk. 2012. Antiplatelet agents and dose adjustment: focus on P2Y12 modulators. University of Namur. Maruyama, Hajime, dkk. 2010. Clopidogrel Resistance and the Effect of Combination Cilostazol in Patients with Ischemic Stroke or Carotid Artery Stenting Using the VerifyNow P2Y12 Assay . Jepang: Department of Neurology, International Medical Center, Saitama Medical University. Jian-Jun, Zou. 2012. CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients. Cina: Department of Clinical Pharmacology, Nanjing Hospital Affiliated to Nanjing Medical University. Vlachojannis, Georgios J,dkk. 2011. Clopidogrel Resistance: Current Aspects and Future Directions.Yunani: Department of Cardiology, Patras University Hospital. Arvanitidis, Kostas. 2007, dkk. Genetic polymorphisms of drug- metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.Yunani: Laboratory of Pharmacology, Medical School, Democritus University of Thrace.
description
m
Transcript of DAFTAR PUSTAKA 9A
DAFTAR PUSTAKA
Zand, Negin, dkk. 2005. Allele Frequency of CYP2C19 Gene Polymorphisms in a Healthy
Iranian Population. Iran : Iran University of Medical Sciences.
Chaudhry, A.S, dkk. 2008. Genetic polymorphism of CYP2C19 & therapeutic response to
proton pump inhibitors. India : Departments of Biochemistry & *Gastroenterology,
Postgraduate Institute of Medical Education & Research, Chandigarh.
Dogné, Jean-Michel, dkk. 2012. Antiplatelet agents and dose adjustment: focus on P2Y12
modulators. University of Namur.
Maruyama, Hajime, dkk. 2010. Clopidogrel Resistance and the Effect of Combination
Cilostazol in Patients with Ischemic Stroke or Carotid Artery Stenting Using the
VerifyNow P2Y12 Assay. Jepang: Department of Neurology, International Medical
Center, Saitama Medical University.
Jian-Jun, Zou. 2012. CYP2C19 polymorphism and antiplatelet effects of clopidogrel in
Chinese stroke patients. Cina: Department of Clinical Pharmacology, Nanjing
Hospital Affiliated to Nanjing Medical University.
Vlachojannis, Georgios J,dkk. 2011. Clopidogrel Resistance: Current Aspects and Future
Directions.Yunani: Department of Cardiology, Patras University Hospital.
Arvanitidis, Kostas. 2007, dkk. Genetic polymorphisms of drug- metabolizing enzymes
CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.Yunani:
Laboratory of Pharmacology, Medical School, Democritus University of Thrace.
Khalaf dkk. 2013. The impact of CYP2C19 *2 and *3 polymorphism on clopidogrel response
following coronary stenting in Saudi patients with acute coronary syndrome. Arab
Saudi: International Genomic Medical Conference (IGMC 2013).
Radji, Maksum. 2005. Pendekatan Farmakogenomik Dalam Pengembangan Obat Baru.
Depok: Departemen Farmasi FMIPA-UI, Universitas Indonesia.
Lakhan, Ram, dkk. Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms
in drug refractory epilepsy. India: Departments of Genetics & *Neurology, Sanjay
Gandhi Postgraduate Institute of Medical Sciences, Lucknow.
Tabari, Robabeh Ghiyas ,dkk. 2013. Genetic Polymorphism of Cytochrome p450 (2C19)
Enzyme in Iranian Turkman Ethnic Group. Iran: Department of Biochemistry and
Biophysics, Metabolic Disorders Research Center, Gorgan Faculty of Medicine,
Golestan University of Medical Sciences.
